The Fund of Funds (FOFs) is the core business of E-Town Capital. It is managed by its subsidiary Beijing E-Town International Industrial Investment Management Co.

The Fund has developed rapidly since its establishment in 2013 through guiding social capital to invest in the equity market and enabling the financial funds to play the roles of lever and amplifier.

By the end of January 2021, the E-town Capital's FOFs had participated in the establishment of over 71 funds worth 648 billion yuan ($88.79 billion).

New-generation information technology, new energy smart vehicles, biotechnology and big health, robotic and intelligent manufacturing are the main investment hot spots for the FOFs of E-town Capital, which has joined in about 1,000 investment projects through market-oriented quality funds that involve a group of influential enterprises, including Semiconductor Manufacturing International Corporation, GigaDevice, Chipone Technology, Will Semiconductor, GOODiX Technology, Vkansee, Megvii Technology, Farasis Energy, Ronbay Technology, Cambricon, Science Sun Pharma, Lepu Medical, Biotech Pharma, Annoroad Gene Technology, car rental company Shenzhou Zhuanche, China's largest on-demand services provider Meituan-Dianping, and the car-hailing company Didi Chuxing.

One of them, Science Sun Pharma, founded in 1999 with the stock code of 300485, is a high-tech enterprise specializing in research and development (R&D), production, and sales of biopharmaceutical products such as active protease, active polypeptide, active polysaccharide, and amphoteric lipids.

Its R&D focuses on drugs for cardiovascular and cerebrovascular diseases, immunomodulation (anti-tumor), nervous system diseases, and bio-polypeptide, new biological materials, and diagnosis and treatment management for chronic diseases. The FOFs of E-town Capital earned six times more than its principal thanks to the investment in Science Sun.

The FOFs earned a rate of return of over 90 percent on its investment on another enterprise, Lepu Medical, which was founded in 1999 with the stock code of 300003.

Lepu Medical has a sales network covering all of China and 95 countries and regions, with an annual revenue of 4.6 billion yuan.

By adhering to the path of technological innovation, leading quality, and cooperative win-win development, Lepu Medical is striving to establish itself as a full-chain player in the cardiovascular medical industry.

The FOFs of E-Town Capital was ranked first among 2016 Chinese governenment guided funds by the China FOFs Alliance and among the Top 10 of both 2016 Chinese Funds of Funds and 2016 Chinese Buyout Funds by the Beijing Private Equity Association, and in 2017 was considered one of the Best Top 10 FOFs of China and China's Best Government-Guided Fund by the magazine Chinese Venture. Pedaily.cn placed it in the Top 20 Limited Partners in China's Private Equity Market in the same year.

In 2018, the FOFs won the CLPA LP100 Case Award and dozens of awards such as Top 20 FOF as regards GP in China, and the Golden Bull Industry-Guided Fund Award.

The FOFs of E-Town Capital has gained strong cooperation opportunities with leading organizations in various vertical industries, its business model has gained recognition from numerous peers, and the company's brand and strength are widely acknowledged by society.